ArticleOral health & preventive dentistry2026
Bioinformatics Identification and Functional Analysis of Key Genes of Nucleotide Metabolism in Oral Squamous Cell Carcinoma.
Article in Oral health & preventive dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeOral squamous cell carcinoma (OSCC) is a typical hypoxic and metabolically heterogeneous adult invasive oral malignant tumour. Nucleotide metabolism-related genes (NMRGs) have been identified as therapeutic targets for various cancers. This study aims to analyse the characteristics of NMRGs in OSCC and identify potential biomarkers. MATERIALS AND
methodsBased on the the Cancer Genome Atlas (TCGA) and GEO data, differentially expressed genes (DEGs) in OSCC were screened and intersected with NMRGs to obtain DE-NMRGs. Key genes were selected through the protein interaction (PPI) network combined with MCC and MCODE algorithms, and receiver operating characteristic (ROC) and survival curves were drawn. Genes with an area under the curve (AUC) > 0.7 and statistically significant differences were selected as hub genes. Further analysis of the immune infiltration characteristics, gene set enrichment analysis (GSEA) enrichment, potential drug effects of hub genes, and construction of the ceRNA network were conducted.
resultsThree hub genes related to nucleotide metabolism (ADA, NT5E, and TYMS) were identified, showing good diagnostic performance (AUC > 0.7). Immune analysis showed that cytotoxic lymphocytes, B lineage, and monocytic lineage had increased infiltration in OSCC (P 0.05). The ceRNA network showed that hsa-miR-30a-5p, hsa-miR-30b-5p interacted with NT5E, and hsa-miR-192-5p, hsa-miR-215-5p interacted with TYMS. Drug prediction suggested that denileukin difitox ontak, STREPTOZOCIN, and nitrogen mustard may be potential therapeutic drugs for OSCC.
conclusionADA, NT5E and TYMS can serve as potential diagnostic markers and therapeutic targets for OSCC. The study has reference value for early diagnosis and the development of individualised treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.